UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Activation of Memory Circuits during Cue-Elicited Cocaine Craving

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (21), p.12040-12045

1996

Link zum Volltext

Verfügbarkeit prüfen

Acupuncture for the treatment of cocaine addiction: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2002-01, Vol.287 (1), p.55

2002

Link zum Volltext

Verfügbarkeit prüfen

Investigating alternative medicine therapies in randomized controlled trials

JAMA : the journal of the American Medical Association, 1998-11, Vol.280 (18), p.1626

1998

Link zum Volltext

Verfügbarkeit prüfen

Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost

The American journal of psychiatry, 1999-01, Vol.156 (1), p.27-33

1999

Link zum Volltext

Verfügbarkeit prüfen

Acupuncture for the treatment of cocaine addiction

JAMA : the journal of the American Medical Association, 2002-04, Vol.287 (14), p.1800; author reply 1801

Cheng, Tsung O

2002

Link zum Volltext

Verfügbarkeit prüfen

Letters to the editor

Complementary therapies in medicine, 1997-03, Vol.5 (1), p.53-54

1997

Link zum Volltext

Verfügbarkeit prüfen

Liabilities Involved in Conducting Randomized Clinical Trials of CAM Therapies in the Absence of Preliminary, Foundational Studies: A Case in Point

The journal of alternative and complementary medicine (New York, N.Y.), 1999-02, Vol.5 (1), p.13-104

Margolin, Arthur

1999

Link zum Volltext

Verfügbarkeit prüfen

Interpreting Conflicting Findings from Clinical Trials of Auricular Acupuncture for Cocaine Addiction: Does Treatment Context Influence Outcome?

The journal of alternative and complementary medicine (New York, N.Y.), 2002-04, Vol.8 (2), p.111-121

2002

Link zum Volltext

Verfügbarkeit prüfen

Addressing the Spiritual Needs of a Drug User Living with Human Immunodeficiency Virus: A Case Study

The journal of alternative and complementary medicine (New York, N.Y.), 2003-02, Vol.9 (1), p.169-175

2003

Link zum Volltext

Verfügbarkeit prüfen

"Self" and Addiction: The Role of Imagery in Self-Regulation

The journal of alternative and complementary medicine (New York, N.Y.), 1995-12, Vol.1 (4), p.339-345

1995

Link zum Volltext

Verfügbarkeit prüfen

Should Cocaine-Abusing, Buprenorphine-Maintained Patients Receive Auricular Acupuncture? Findings from an Acute Effects Study

The journal of alternative and complementary medicine (New York, N.Y.), 1999-12, Vol.5 (6), p.567-574

1999

Link zum Volltext

Verfügbarkeit prüfen

New Developments in Opioid Abuse Treatment

Annals of clinical psychiatry, 1990, Vol.2 (4), p.245-250

1990

Link zum Volltext

Verfügbarkeit prüfen

Rationale and Design of the Cocaine Alternative Treatments Study (CATS): A Randomized, Controlled Trial of Acupuncture

The journal of alternative and complementary medicine (New York, N.Y.), 1998-12, Vol.4 (4), p.45-418

1998

Link zum Volltext

Verfügbarkeit prüfen

Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)

JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (22), p.2983

2003

Link zum Volltext

Verfügbarkeit prüfen

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

Melanoma management, 2017-03, Vol.4 (1), p.13-37

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT032: CMP-001 demonstrates improved response in noninflamed anti-PD-1 refractory melanoma and response is associated with serum CXCL10

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT032-CT032

2021

Link zum Volltext

Verfügbarkeit prüfen

950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A999-A999

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT144-CT144

2018

Link zum Volltext

Verfügbarkeit prüfen

304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A331-A331

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

Journal of clinical oncology, 1993-04, Vol.11 (4), p.661-670

1993

Link zum Volltext

Verfügbarkeit prüfen

O85 Durable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab

Journal for immunotherapy of cancer, 2020-04, Vol.8 (Suppl 1), p.A2-A3

2020

Link zum Volltext

Verfügbarkeit prüfen

29th Annual meeting of the Society for Immunotherapy of Cancer (SITC)

Journal for immunotherapy of cancer, 2015-05, Vol.3 (1), Article 17

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Humans
(13)
Life Sciences & Biomedicine
(13)
Female
(9)
Adult
(8)
Male
(8)
Cocaine-Related Disorders - Therapy
(6)
Immunotherapy
(5)
Integrative & Complementary Medicine
(5)
Biological And Medical Sciences
(4)
General & Internal Medicine
(4)
Medical Sciences
(4)
Medicine, General & Internal
(4)
Melanoma
(4)
Treatment Outcome
(4)
Acupuncture, Ear
(3)
Care And Treatment
(3)
Clinical Trials
(3)
Evaluation
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of Memory Circuits during Cue-Elicited Cocaine Craving

Acupuncture for the treatment of cocaine addiction: a randomized controlled trial

Investigating alternative medicine therapies in randomized controlled trials

Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost

Acupuncture for the treatment of cocaine addiction

Letters to the editor

Liabilities Involved in Conducting Randomized Clinical Trials of CAM Therapies in the Absence of Preliminary, Foundational Studies: A Case in Point

Interpreting Conflicting Findings from Clinical Trials of Auricular Acupuncture for Cocaine Addiction: Does Treatment Context Influence Outcome?

Addressing the Spiritual Needs of a Drug User Living with Human Immunodeficiency Virus: A Case Study

"Self" and Addiction: The Role of Imagery in Self-Regulation

Should Cocaine-Abusing, Buprenorphine-Maintained Patients Receive Auricular Acupuncture? Findings from an Acute Effects Study

New Developments in Opioid Abuse Treatment

Rationale and Design of the Cocaine Alternative Treatments Study (CATS): A Randomized, Controlled Trial of Acupuncture

Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS)

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy

Abstract CT032: CMP-001 demonstrates improved response in noninflamed anti-PD-1 refractory melanoma and response is associated with serum CXCL10

950 Final analysis: phase 1b study investigating intratumoral injection of toll-like receptor 9 agonist vidutolimod ± pembrolizumab in patients with PD-1 blockade–refractory melanoma

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

O85 Durable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab

29th Annual meeting of the Society for Immunotherapy of Cancer (SITC)

Aktive Filter

Suchergebnisse filtern